Orv Hetil. 2022 Jan 30;163(5):171-180. doi: 10.1556/650.2022.32409. Print 2022 Jan 30.
PMID:35093925
Primary immunodeficiency and chronic mucocutaneous candidiasis: pathophysiological, diagnostic, and therapeutic approaches.
Egri N, Esteve-Solé A, Deyà-Martínez À, Ortiz de Landazuri I, Vlagea A, García AP, Cardozo C, Garcia-Vidal C, Bartolomé CS, Español-Rego M, Yiyi L, Bosch-Amate X, Ferrando J, Yagüe J, Juan M, Alsina L.
Allergol Immunopathol (Madr). 2021 Jan 2;49(1):118-127. doi: 10.15586/aei.v49i1.20. eCollection 2021.
PMID:33528939
Chronic mucocutaneous candidiasis: what can we conclude about IL-17 antagonism?